` APTA (Aptamer Group PLC) vs FTSE All Share Index Comparison - Alpha Spread

A
APTA
vs
F
FTSE All Share Index

Over the past 12 months, APTA has significantly outperformed FTSE All Share Index, delivering a return of +135% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
APTA vs FTSE All Share Index

Loading
APTA
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
APTA vs FTSE All Share Index

Loading
APTA
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
APTA vs FTSE All Share Index

Loading
APTA
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Aptamer Group PLC vs Peers

FTSE All Share Index
APTA
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Aptamer Group PLC
Glance View

Market Cap
25.6m GBX
Industry
Biotechnology

Aptamer Group Plc operates as a biotechnology company. The firm provides custom Optimer selection and development services. The firm provides transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. The firm has developed a proprietary platform technology that drives three distinct businesses: Aptamer solutions for custom Optimer development, Aptamer diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer therapeutics for the development of Optimer-based therapeutics. Optimer can act as agonists, antagonists or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.

APTA Intrinsic Value
0.23 GBX
Overvaluation 75%
Intrinsic Value
Price
A
Back to Top